Filing Details
- Accession Number:
- 0001225208-16-043118
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-13 18:51:06
- Reporting Period:
- 2016-12-09
- Filing Date:
- 2016-12-13
- Accepted Time:
- 2016-12-13 18:51:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1403373 | A John Deford | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Sr. Vp Sci Tech And Clin Afrs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-12-09 | 3,292 | $186.43 | 24,899 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-12-09 | 3,292 | $215.00 | 21,607 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-12-12 | 4,663 | $97.69 | 26,270 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-12-12 | 4,161 | $136.37 | 30,431 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-12-12 | 3,767 | $168.87 | 34,198 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-12-12 | 826 | $218.83 | 33,372 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-12-12 | 1,977 | $220.38 | 31,395 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-12-12 | 4,167 | $216.98 | 27,228 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-12-12 | 5,621 | $219.63 | 21,607 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2016-12-09 | 3,292 | $0.00 | 3,292 | $186.43 |
| Common Stock | Option (Right to Buy) | Disposition | 2016-12-12 | 3,767 | $0.00 | 3,767 | $168.87 |
| Common Stock | Option (Right to Buy) | Disposition | 2016-12-12 | 4,161 | $0.00 | 4,161 | $136.37 |
| Common Stock | Option (Right to Buy) | Disposition | 2016-12-12 | 4,663 | $0.00 | 4,663 | $97.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,879 | 2025-12-09 | No | 4 | M | Direct | |
| 7,535 | 2024-12-10 | No | 4 | M | Direct | |
| 4,161 | 2023-12-11 | No | 4 | M | Direct | |
| 0 | 2022-12-12 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 71 | Indirect | 401(k) Plan |
Footnotes
- Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
- Includes 0.0632 shares acquired under the Company's Dividend Reinvestment Plan from July 30, 2016 to November 4, 2016. Includes 0.001 shares acquired under the Company's Employee Stock Purchase Plan from August 2, 2016 to November 7, 2016.
- Represents the weighted average sales price for price increments ranging from $218.17 to $219.10. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $220.18 to $220.78. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $216.62 to $217.23. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $219.18 to $220.17. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Includes 0.101 shares acquired under the Company's 401(k) Plan from July 30, 2016 to November 4, 2016.
- Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Of this option grant 3,292 options vested on December 9, 2016 and the remaining options vest in three annual installments beginning on December 9, 2017.
- Of this option grant 3,767 options vested on December 10, 2016 and the remaining options vest in two annual installments beginning on December 10, 2017.
- Of this option grant 4,161 options vested on December 11, 2016 and the remaining options vest on December 11, 2017.
- Options fully vested and are currently exercisable.
Billionaire Hedge Funds
